| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Atara Biotherapeutics, Inc. (ATRA) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. ATRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.32M | $13.97M | - | |
| CEO | 143.1K | $1.51M | - | |
| Other | 52.0K | $549.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2017 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 4,400 | $13.47 | $59,268.00 | -0.5% | |
| Oct 27, 2017 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 4,400 | $13.59 | $59,774.00 | -0.5% | |
| Oct 16, 2017 | Haqq Christopher | EVP, R&D &Chief Scientific Of | Sell | 6,000 | $14.35 | $86,100.00 | -1.7% | |
| Oct 12, 2017 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 4,400 | $15.02 | $66,066.00 | -0.5% | |
| Sep 20, 2017 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 4,400 | $15.54 | $68,354.00 | -0.5% | |
| Sep 15, 2017 | Haqq Christopher | EVP, R&D &Chief Scientific Of | Sell | 6,000 | $15.30 | $91,800.00 | -1.7% | |
| Sep 7, 2017 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 4,400 | $15.02 | $66,066.00 | -0.5% | |
| Aug 23, 2017 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 4,400 | $13.54 | $59,554.00 | -0.5% | |
| Aug 16, 2017 | Gallagher Carol Giltner | Director | Sale+OE | 1,184 | $14.30 | $16,931.20 | -1.1% | |
| Aug 16, 2017 | Soffer Gad | EVP &Chief Strategy Officer | Sale+OE | 9,464 | $14.88 | $140,801.92 | -1.8% |